Mohammad Alqahtani1, Elie Ganni1, Thomas Mavrakanas2, Michael Tsoukas3, Tricia Peters4, Rita Suri2, I George Fantus3, Antonina Pavilanis5, Julian Guida5, Amir Razaghizad5, Abhinav Sharma6,7,8. 1. Division of Internal Medicine, McGill University Health Centre, McGill University, Montreal, QC, Canada. 2. Division of Nephrology, McGill University Health Center, McGill University, Montreal, QC, Canada. 3. Division of Endocrinology and Metabolism, McGill University Health Center, McGill University, Montreal, QC, Canada. 4. Division of Endocrinology and Metabolism, Jewish General Hospital, McGill University, Montreal, QC, Canada. 5. DREAM-CV Lab, McGill University Health Centre Research Institute, McGill University, Montreal, QC, Canada. 6. Division of Cardiology, McGill University Health Centre, Montreal, QC, Canada. Abhinav.sharma@mail.mcgill.ca. 7. DREAM-CV Lab, McGill University Health Centre Research Institute, McGill University, Montreal, QC, Canada. Abhinav.sharma@mail.mcgill.ca. 8. McGill University Health Centre, 1001 Decarie Blvd, Montreal, QC, H4A 3J1, Canada. Abhinav.sharma@mail.mcgill.ca.
Abstract
PURPOSE OF REVIEW: The current care model of type 2 diabetes (T2D) and its complications appears to be "asynchronous" with patient care divided by specialty. This model is associated with low use of guideline-directed medical therapies. RECENT FINDINGS: The use of integrated care models has been well described in the management of patients with T2D; this usually includes an endocrinologist coupled with a nutritionist and nurse. However, physician-based care models are largely "asynchronous," whereby the patient requires multiple different siloed specialties to manage their health care. To date, there has been limited exploration of synchronous care delivery, i.e., whereby multi-comorbid patients with T2D are seen simultaneously by health care providers from endocrinology, cardiology, and nephrology to optimize use of guideline-directed medical therapies (GDMT). Given the rising complexity of patients with T2D, further research is needed on the role of synchronous health care delivery in optimizing the use of GDMT and improving patient outcomes.
PURPOSE OF REVIEW: The current care model of type 2 diabetes (T2D) and its complications appears to be "asynchronous" with patient care divided by specialty. This model is associated with low use of guideline-directed medical therapies. RECENT FINDINGS: The use of integrated care models has been well described in the management of patients with T2D; this usually includes an endocrinologist coupled with a nutritionist and nurse. However, physician-based care models are largely "asynchronous," whereby the patient requires multiple different siloed specialties to manage their health care. To date, there has been limited exploration of synchronous care delivery, i.e., whereby multi-comorbid patients with T2D are seen simultaneously by health care providers from endocrinology, cardiology, and nephrology to optimize use of guideline-directed medical therapies (GDMT). Given the rising complexity of patients with T2D, further research is needed on the role of synchronous health care delivery in optimizing the use of GDMT and improving patient outcomes.
Authors: Lauren A Eberly; Lin Yang; Nwamaka D Eneanya; Utibe Essien; Howard Julien; Ashwin S Nathan; Sameed Ahmed M Khatana; Elias J Dayoub; Alexander C Fanaroff; Jay Giri; Peter W Groeneveld; Srinath Adusumalli Journal: JAMA Netw Open Date: 2021-04-01